Clearance Summary
CYTOSCAN(R) DX received FDA 510(k) clearance under submission number DEN130018, sponsored by Affymetrix, Inc.. The device was reviewed via the Post-NSE premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2014-01-17.
- Submission: DEN130018
- Applicant / Sponsor: Affymetrix, Inc.
- Clearance pathway: Post-NSE
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5920
- Decision date: 2014-01-17
Classification & Regulation
This clearance is catalogued under FDA product code PFX and 21 CFR 866.5920, within the Immunology review panel as a Class II device.